Matthew K. Szot

Matthew K. Szot is a declared insider at 4 companies (finance chief); the most frequent names are Cadrenal Therapeutics, Inc., S&W Seed Co and INVO Fertility, Inc. Over a trading history stretching from 1 January 2016 to 29 December 2025, the count stands at 19 filings.

Both buying and selling appear: 1 purchase worth €13k, against 11 sales worth €162k. The totals do not cover 1 filing with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 4 share grants and 3 option exercises. 2025 to date brings no purchases and 10 sales.

The latest filing, published on 31 December 2025, reports an open-market sale of €59k in Cadrenal Therapeutics, Inc. The most recent open-market purchase was published on 3 June 2022, 1,598 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.